ArticleFrontiers in clinical diabetes and healthcare2026
Economic impact of education and empowerment interventions in diabetes care: a two-year prospective longitudinal analysis in a tertiary care population.
Article in Frontiers in clinical diabetes and healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetes mellitus imposes a substantial economic burden on patients and healthcare systems, particularly in low- and middle-income countries. Objective: To evaluate longitudinal changes in direct and indirect costs of diabetes care and identify predictors of cost reduction following an educational and empowerment-based intervention. Methods: A prospective longitudinal controlled interventional study (quasi-experimental) was conducted over 24 months among adults with type 2 diabetes mellitus at a tertiary care hospital. Patient-level data on direct medical expenses, ancillary costs, and clinical parameters were analyzed using mixed-effects and regression models. Results: A significant reduction in direct cost and ancillary fees, such as travel and parking, was observed from baseline to 24 months (p<0.001). Mixed-effects modeling confirmed significant temporal reductions in costs at each follow-up (β = -3,117.05 at 24 months; 95% CI: -3,224.01 to -3,010.09). Furthermore, clusters of moderate, gradual, and high responders were identified. Multivariable regression showed that baseline cost (β = 0.582, p<0.001) and HbA1c (β = -611.53, p < 0.001) as independent predictors of cost reduction. Conclusion: Education and empowerment lead to reductions in direct and indirect costs over two years, suggesting improved cost efficiency in diabetes mellitus management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.